ArticleThe Lancet. Haematology2022

In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.

David I Marks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.